BiomedicalPublications

JACC CardioOncology

Elsevier BV·United States·ISSN 2666-0873

Open accessIn DOAJFee waivers availableMedicine

JACC CardioOncology is published by Elsevier BV as an open access journal (ISSN 2666-0873). The list article processing charge is $4,200. Typical time to publication is 16 wks. Its OpenAlex h-index is 63. Primary field: Medicine. It is listed in the Directory of Open Access Journals. Fee waivers are stated as available. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

$4,200

Open-access article processing charge, list price.

Checked · Journal fee page

Time to publication

16 wks

Broadly typical for the field.

h-index

63

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

6.5

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in JACC CardioOncology is listed at $4,200. The publisher also lists 3,930 EUR, 3,360 GBP, 520,930 JPY. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in JACC CardioOncology, as recorded by OpenAlex for each year. The fee has risen 68% since 2021, from $2,500 to $4,200.

$0$2.1k$4.2k2021: $2,50020212022: $2,50020222023: $3,39620232024: $3,86620242025: $4,2002025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY, CC BY-NC-ND
Author keeps copyrightNo
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects JACC CardioOncology publishes most, derived from the topics assigned to its indexed articles.

Chemotherapy-induced cardiotoxicity and mitigationCardiac Imaging and DiagnosticsAmyloidosis: Diagnosis, Treatment, OutcomesCancer Treatment and PharmacologyCardiovascular Function and Risk FactorsVenous Thromboembolism Diagnosis and ManagementCardiac tumors and thrombiCancer Immunotherapy and BiomarkersChildhood Cancer Survivors' Quality of LifeParathyroid Disorders and Treatments

Publication record

Indexed articles975
Total citations16,118
i10-index340
Most recent indexed article2026
Open access since2019
All ISSNs2666-0873

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.